Evidence map›Paper›PMID 14526002›Full record

ArticleJournal of bacteriology2003

Redefining the role of psr in beta-lactam resistance and cell autolysis of Enterococcus hirae.

Frédéric Sapunaric, Christine Franssen, Patrick Stefanic, Ana Amoroso, Olivier Dardenne, Jacques Coyette

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Frédéric SapunaricDepartment of Molecular Biology and Microbiology, School of Medicine, Tufts University, Boston, Massachusetts 02111, USA.
Christine Franssen
Patrick Stefanic
Ana Amoroso
Olivier Dardenne
Jacques Coyette
University of Liège · BEShriners Hospitals for Children - Canada · CATufts University · USUniversity of Buenos Aires · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The contribution of penicillin-binding protein 5 (PBP5) and the PBP5 synthesis repressor (Psr) to the beta-lactam resistance, growth, and cell autolysis of wild-type strain ATCC 9790 and resistant strain R40 of Enterococcus hirae was investigated by disruption or substitution of the corresponding pbp5 and psr genes by Campbell-type recombination. The resulting modifications were confirmed by hybridization and PCR. The low susceptibility of E. hirae to beta-lactams was confirmed to be largely dependent on the presence of PBP5. However, against all expectations, inactivation of psr in ATCC 9790 or complementation of R40 cells with psr did not modify the susceptibility to benzylpenicillin or the growth and cell autolysis rates. These results indicated that the psr gene does not seem to be involved in the regulation of PBP5 synthesis and consequently in beta-lactam resistance or in the regulation of cell autolysis in E. hirae.

Indexed as

Bacteriolysisbeta-Lactam ResistanceAnti-Bacterial AgentsBacterial ProteinsBase SequenceCarrier ProteinsEnterococcusGene Expression Regulation, BacterialHexosyltransferasesMicrobial Sensitivity TestsMolecular Sequence DataMuramoylpentapeptide CarboxypeptidaseMutationPenicillin-Binding ProteinsPeptidyl TransferasesRecombination, GeneticAnti-Bacterial AgentsBacterial ProteinsCarrier ProteinsHexosyltransferasesMuramoylpentapeptide CarboxypeptidasePenicillin-Binding ProteinsPeptidyl TransferasesPsr protein, Enterococcus hiraeRepressor Proteins

Identifiers

PMID14526002
PMCPMC225013
OpenAlexW2148918797

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.